A sensitive flow cytometric methodology for studying the binding of L. chagasito canine peritoneal macrophages
© Gonçalves et al; licensee BioMed Central Ltd. 2005
Received: 31 August 2004
Accepted: 24 May 2005
Published: 24 May 2005
The Leishmania promastigote-macrophage interaction occurs through the association of multiple receptors on the biological membrane surfaces. The success of the parasite infection is dramatically dependent on this early interaction in the vertebrate host, which permits or not the development of the disease. In this study we propose a novel methodology using flow cytometry to study this interaction, and compare it with a previously described "in vitro" binding assay.
To study parasite-macrophage interaction, peritoneal macrophages were obtained from 4 dogs and adjusted to 3 × 106 cells/mL. Leishmania (Leishmania) chagasi parasites (stationary-phase) were adjusted to 5 × 107 cells/mL. The interaction between CFSE-stained Leishmania chagasi and canine peritoneal macrophages was performed in polypropylene tubes to avoid macrophage adhesion. We carried out assays in the presence or absence of normal serum or in the presence of a final concentration of 5% of C5 deficient (serum from AKR/J mice) mouse serum. Then, the number of infected macrophages was counted in an optical microscope, as well as by flow citometry. Macrophages obtained were stained with anti-CR3 (CD11b/CD18) antibodies and analyzed by flow citometry.
Our results have shown that the interaction between Leishmania and macrophages can be measured by flow cytometry using the fluorescent dye CFSE to identify the Leishmania, and measuring simultaneously the expression of an important integrin involved in this interaction: the CD11b/CD18 (CR3 or Mac-1) β2 integrin.
Flow cytometry offers rapid, reliable and sensitive measurements of single cell interactions with Leishmania in unstained or phenotypically defined cell populations following staining with one or more fluorochromes.
Leishmaniasis is a disease resulting from infection by protozoa of the genus Leishmania, which affects man and several other species of mammals. In the new world Leishmania is transmitted to man and animals by blood-sucking sandflies of the species Lutzomyia longipalpis [1–3]. Infection is initiated when the sandfly regurgitates infectious forms of promastigotes, termed "metacyclics" , into a small pool of blood formed by the blood-sucking female . Upon inoculation of the host, promastigotes are phagocytized by skin macrophages, where they transform into aflagellar ovoid bodies known as amastigotes. In mammals, Leishmania are dimorphic obligate intracellular parasites, which reside and multiply mainly within the phagolysosomal compartment of mononuclear phagocytes [6–8]. Depending on the species, the parasite or infected macrophages, may spread and give rise to secondary infections in distant organs, producing distinct clinical forms of the disease . Thus, the pathogenesis of Leishmania infections depends to a large extent on the relationship between the parasites and host macrophages.
The interaction of Leishmania promastigotes with mononuclear phagocytes has been characterized, and multiple receptor-ligand interactions have been implicated to play a role in the attachment to, and uptake of, promastigotes by macrophages . These interactions include the binding of parasite surface molecules (lipophosphoglycan and gp63) or host derived opsonins (complement, fibronectin and immunoglobulin) to multiple macrophage receptors. The best characterized of these systems is the binding of serum complement opsonized promastigotes to macrophage receptors for complement . Complement-dependent opsonization of parasites not only improves their adhesion to macrophages, but also enhances their intracellular survival . Although the direct interaction of promastigotes with macrophages, in the absence of opsonization, has been well established for several species of Leishmania, the identity of the macrophage receptors involved in this interaction, and to a lesser extent, the ligands on the surface of promastigotes, remains unresolved . The macrophage complement receptor Mac-1 (CD11b/CD18 or CR3) has been demonstrated to be crucial for the interaction of serum opsonized promastigotes with both human and murine macrophages [10, 13–15].
In the literature, there are many "in vitro" methods describing the Leishmania-macrophage interaction. These techniques are performed quantifying parasites and macrophages over coverslips where parasites can be counted by conventional microscopy, immunofluorescent microscopy (immunolabelled parasites) or radioactivity associated with the cell lysates determined by a scintillation counter [11, 14, 16, 17]. However, these techniques are laborious, time consuming, and do not allow an accurate characterization of the cells and surface receptors involved with parasite uptake. Moreover, most of these studies involve human or murine monocytes-macrophages and Leishmania major. "In vitro" studies using canine macrophages and Leishmania chagasi are rare in the literature. As far as we know, Marzochi et al. (1999) were the first to report binding-assays between different species of Leishmania and canine macrophages .
In this study we propose a flow cytometric method to study peritoneal canine macrophage-Leishmania chagasi interaction by a binding assay using the stable intra-cytoplasmic fluorocrome, 5,6-carboxyfluorescein diacetate succinimidyl ester (CFSE) . This methodology is less laborious than cell-cultures techniques, and is not limited by the subjective and time-consuming nature of microscopy, necessary to calculate parasitism ratios. Moreover, when associated with conventional flow cytometry analysis, this technique also allows the phenotypic characterization of the infected cells and the identification of the cell surface molecules involved in parasite uptake. Lastly, this method allows for the analysis of large populations of cells rather than the limited number that must be analyzed using microscopy.
Four mongrel dogs of unknown age were obtained from the City of Sabará (Suburban area of Belo Horizonte, City) (City hall Zoonosis Department), MG, Brazil. All dogs were negative for Leishmania by direct immunofluorescence (RIFI) and complement fixation tests (RFC). The dogs received anti-helminth and anti-ectoparasite treatment. Animals were maintained in quarantine with food and water "ad libidum". All animal studies were performed under the guidance and approval of the institutes' animal welfare committee under the supervision of a certified veterinarian.
The experiment protocol using dogs, was approved by CETEA (COMITÊ DE ÉTICA EM EXPERIMENTAÇÃO ANIMAL – UFMG), by number 034/2004.
Obtaining the Peritoneal cells
For obtaining the peritoneal macrophages the dogs were sacrificed using a lethal dose (0,3 ml/Kg) of T-61® drug (Intervet). The animals were positioned in decumbency and the peritoneal cavity was disinfected using alcohol-iodine-alcohol and washed with sterile PBS (Phosphate-Buffered Saline). The peritoneal cavity was opened by a 10 cm incision along the medial line using a sterile scalpel. Next, 700 to 900 mL of sterile cold PBS was added to the cavity and mixed. The PBS was collected using a 60 mL sterile syringe and poured into several 50 mL conical centrifuge tubes on ice. Immediately the cells were centrifuged at 250 g, 4°C, 15 minutes and the supernatant was discarded. Washed peritoneal cell suspensions were adjusted to 3 × 106 cells/mL in culture medium (D-10 - DMM + 10% fetal calf serum (FCS) + L-glutamine + penicillin-streptomycin).
Obtaining the parasites
Leishmania (Leishmania) chagasi parasites (stationary-phase) were adjusted to 5 × 107 cells/mL in "phagocytosis buffer" culture medium (equal parts of Dulbecco's Modified Eagle Medium and Medium 199 supplemented with1% of BSA and 12,5 mM HEPES) .
The CFSE (carboxyfluorescein diacetate succinimidyl ester – Molecular Probes C-1157) dye was used as previously described . Briefly, parasites were washed twice, in PBS 1,200 g, 10 minutes, 4°C. Parasites were resuspended in 1 mL of PBS (5 × 107 parasites/mL) with × nM of CFSE (using a stock of 2.8 μg/mL in DMSO) and incubated in a 37°C water bath for 10 minutes in the dark.. After this, they were washed in 10 mL of cold PBS + 10% of fetal bovine serum and centrifuged at 1,200 g. The pellet was diluted in phagocytosis buffer culture medium protected in the dark.
We have tested the viability and vitality of the CFSE-stained Leishmania, by observing their mobility under the light microscope. The fluorescence was confirmed by observing stained Leishmania using a fluorescent microscope. Dyed parasites were also used to infect mice (BALB/c) and hamsters to observe their virulence. The spleen and liver were collected after 4 weeks of infection and slides were prepared for analysis using light microscopy. The results indicated that CFSE stained parasites have an equivalent infective capacity as non-stained parasites (data not shown).
Leishmania binding assay
The interaction between CFSE-stained Leishmania-chagasi and canine peritoneal macrophages was performed in polypropylene tubes to avoid macrophage adhesion. 100 μL of macrophages (3 × 105 cells) and 100 μL of CFSE stained-Leishmania chagasi (5 × 106 cells) were combined in the tubes and maintained for 45–60 minutes at 37°C in a 5% CO2 environment.
We carried out assays in the presence of normal serum or in the presence of a final concentration of 5% of C5 deficient (serum from AKR/J mice) mouse serum .
Specific staining with anti-CR3 (CD11b/CD18)
Macrophages obtained as described above were stained with anti-CR3 (CD11b/CD18) rat anti-Human CD18-RPE antibody (Serotec) that shows cross reactivity with canine cells. Non-conjugated, purified Mouse anti-Canine CD11b (Serotec) conjugated using the Kit Zenon tricolor (Molecular probes – Z-25080) as described by the manufacturer with the "C" compound that represent a 647 nm emission band and can be used with CFSE and R-PE. Cells were incubated with labeled antibody solutions for 20 min at 4°C. After staining, preparations were washed with 0.1% sodium azide PBS, fixed with 200 μl of 2% formaldehyde in PBS and kept at 4°C until data were acquired using a flow cytometer (FACSVantage, Becton & Dickinson, San José, CA, USA).
Flow cytometry analysis
The cells were run on an analytical flow cytometer equipped with a laser emitting at 488 nm (FACSVantage, Becton-Dickinson, San Diego, CA, USA). Whole cells were excluded from fragments by gating based on the forward and side scatter signals. CFSE-stained promastigotes bound to macrophages were detected according to their relative fluorescence intensities using the FL1 (green) detector as compared to those of uninfected cells. Both the frequency of cells associated with Leishmania, as well as the intensity of cells associated with Leishmania was determined. Analyses were performed on 40,000 to 100,000 gated events, and numeric data were processed with WinMDI software version 2.8 (Joseph Trotter: http://facs.scripps.edu/software.html#winapps).
In order to confirm the intensity of macrophages binding with dyed Leishmania, we did an experimental "in vitro" assay using different macrophage/ parasite in ratios of : 1:1, 1:2, 1:5, 1:10, 1:15, 1:20 and 1:30 Macrophages:Leishmania).
Results are given as complete randomized design and the means from each group were compared using "student t test". P value less than 0.05 was considered significant.
Evaluation of CR3 expression using flow cytometry
American Visceral Leishmaniasis (AVL) is a zoonosis with dogs representing the principal domestic reservoir of the disease. AVL is present in at least a dozen Latin American countries, with 90% of human cases reported from Brazil, especially the north-eastern region [1–3, 18, 21, 22]. Canine Visceral Leishmaniasis (CVL) appears to be spreading further in Brazil, and outbreaks have occurred in major Brazilian cities in the northeast of the country, such as Teresina, (PI), São Luiz (Maranhão), Fortaleza (Ceará), Salvador (Bahia), [23, 24] and also in the southeast as in Belo Horizonte, [25, 26] and Rio de Janeiro (RJ) . These urban or predominantly peri-urban outbreaks appear to be increasing, but historically they are cyclical and recur following several year intervals of low endemicity. Domestic dogs have been the target of intense research concerning leishmaniasis with hopes of improving control of infected animals, and due to findings that show common clinical, immunological and pathologic aspects with human visceral disease. [27–34].
Macrophages are the main cells involved in the pathogenesis of the disease and they represent an ideal target cell population for "in vitro"studies. However, data concerning the behaviour of canine macrophages from naturally or experimentally infected animals with Leishmania chagasi, "in vitro", are limited. In this work we have demonstrated a reliable and practical method to quantify the frequency and intensity of host cells bound with Leishmania. This methodology is less laborious and more quantitative than cell-cultures techniques, removing the disadvantages of subjectivity and the time-consuming nature of microscopy when establishing parasitism ratios.
Our results, using the conventional Leishmania-binding assay, have confirmed previous work in the literature  where it has been demonstrated that the number of parasites bound to macrophages was dramatically increased when using serum containing complement. Importantly, these same results were obtained using analysis by flow cytometry with CFSE stained Leishmania. Moreover, a strong correlation was seen between both conventional microscopy based methods and our flow cytometry based approach.
In addition, this methodology permits the simultaneous use of conventional flow cytometry analysis to quantify the expression of membrane receptors related to Leishmania-macrophage interactions. For example, we have performed assays to determine the expression of CD11b/CD18 (CR3) [14, 36] integrins involved in the interaction of Leishmania promastigotes with canine macrophages. Moreover, the MFI of macrophages associated with Leishmania increased with higher parasite/macrophage ratios, indicating a direct correlation between the number of parasites and the intensity of interaction with the host macrophage. Finally, other phenotypic markers can be used to clearly characterize the infected population and to describe functional characteristics of cell subpopulations through the analysis of cytokines and activation markers.
Our results have shown that CR3 (CD11b/CD18) receptor expression is lower in the presence of promastigote forms of Leishmania. Since we have performed binding-assays (not infection assays) we can consider that these receptors are either occupied by Leishmania binding, or that the receptor complexes have been internalized. Future "in vitro" studies are being carried out in our laboratory to resolve this question.
Several studies have been designed to study the interaction of parasites and macrophages. The majority used dead microorganisms (bacteria or fungi), inert or fluorescent particles (latex/polystyrene beads or zimozan), lamb's hematia, or finally, microorganisms labelled with antibodies . The use of antibody labelled-living L. amazonensis was shown by Bertho et al (1992) as a poor method, because labelling antibodies were shed too quickly . We have found a staining method using living-parasites that can be used without interfering with the interaction between macrophages and parasites, and it represents a stable association of the fluorescence with the parasite. The stability of the CFSE staining has been largely employed in other studies using living cells [39–42], and was recently used for staining and tracking the association of T. cruzi with host cells as well .
While CFSE is typically used in proliferation assays , our novel studies have defined another use for this marker to analyze the interaction between a parasite and host cells.
In this work we propose a method for the study of the interaction between live Leishmania and macrophages using flow cytometry. Moreover, we have also demonstrated a system that can be useful for studies of the interaction of L. chagasi with canine peritoneal macrophages. These techniques open the door to many future studies designed to further investigate the interaction of Leishmania with host cell populations. Finally, CFSE stained Leishmania have been shown to be stable for many days, and could be used to study phagocytosis or Leishmania-survival.
Doctor Alan Lane de Melo for gently providing the C5 deficient mice (AKR/J). - Laboratório de taxonomia e biologia de invertebrados do Departamento de Parasitologia da UFMG. This work was supported by Fundação de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG grant CDS2263/97) and Consellho Nacional de Desenvolvimento da Pesquisa Tecnológica e Científica - (grant CNPq 472287/01-0 – NV), and CT-INFRA-FINEP, Brazil. This investigation also received financial support from the UNICEF/UNDP/World bank/WHO Special Program for Research and Training in Tropical Diseases (TDR).
- Lainson R, Shaw JJ: Epidemiology and ecology of leishmaniasis in Latin America. Nature. 1978, 273: 595-View ArticlePubMedGoogle Scholar
- Grimaldi G, Tesh RB, Mc Mathon-Pratt DA: A review of the geographic distribution and epidemiology of Leishmaniasis in the New World. Am J Trop Med Hyg. 1989, 41: 687-PubMedGoogle Scholar
- Ashford RW: The Leishmaniasis as emerging and reemerging zoonoses. Int J Parasitol. 2000, 30: 1269-10.1016/S0020-7519(00)00136-3.View ArticlePubMedGoogle Scholar
- Sacks DL: Metacyclogenesis in Leishmania promastigotes. Exp Parasitol. 1989, 69: 100-10.1016/0014-4894(89)90176-8.View ArticlePubMedGoogle Scholar
- Schlein Y: Leishmania and Sandflies: Interactions In life cycle and transmission. Parasitol Today. 1993, 9: 255-10.1016/0169-4758(93)90070-V.View ArticlePubMedGoogle Scholar
- Chang KP: Leishmania donovani: Promastigote-macrophage surface interactions in vitro. Exp Parasitol. 1979, 48: 175-10.1016/0014-4894(79)90097-3.View ArticlePubMedGoogle Scholar
- Russel DG, Talamas-Rohana P: Leishmania and the macrophage: a marriage of inconvenience. Immunol Today. 1989, 10: 328-10.1016/0167-5699(89)90188-6.View ArticleGoogle Scholar
- Mosser DM, Rosenthal LA: Leishmania-macrophage interactions: multiple receptors, multiple ligands and diverse cellular responses. Semin Cell Biol. 1993, 4: 315-10.1006/scel.1993.1038.View ArticlePubMedGoogle Scholar
- Mauel J: Macrophage-parasite interactions in Leishmania infection. J Leukoc Biol. 1990, 47: 187-PubMedGoogle Scholar
- Mosser DM, Edelson PJ: The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes. J Immunol. 1985, 135: 2785-PubMedGoogle Scholar
- Mosser DM, Edelson PJ: The third component of complement C3 is responsible for in the intracellular survival of Leishmania major. Nature. 1987, 327: 329-10.1038/327329b0.View ArticlePubMedGoogle Scholar
- Kane MM, Mosser DM: Leishmania parasites and their ploys to disrupt macrophage activation. Curr Opin Hematol. 2000, 7 (suppl 1): 26-10.1097/00062752-200001000-00006.View ArticlePubMedGoogle Scholar
- Mosser DM, Springer TA, Diamond MS: Leishmania promastigotes require opsonic complement to bind to the human leucocyte integrin Mac-1 (CD11b/CD18). J Cell Biol. 1992, 116: 511-10.1083/jcb.116.2.511.View ArticlePubMedGoogle Scholar
- Rosenthal LA, Sutterwala FS, Kehrli ME, Mosser DM: Leishmania-major -human macrophage interactions: cooperation between Mac-1 (CD11b/CD18) and complement receptor type 1 (CD35) in promastigote adhesion. Infect Immun. 1996, 64: 2206-PubMedPubMed CentralGoogle Scholar
- Handman E, Bullen DV: Interaction of Leishmania with the host macrophage. Trends Parasitol. 2002, 18 (8): 332-10.1016/S1471-4922(02)02352-8.View ArticlePubMedGoogle Scholar
- Mosser DM, Handman E: Treatment of murine macrophages with interferon-gamma inhibits their ability to bind Leishmania promasigotes. J Leukoc Biol. 1992, 52: 369-PubMedGoogle Scholar
- Brittingham A, Morrison CJ, McMaster R, McGwire BS, Chang KP, Mosser DM: Role of Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. J Immunol. 1995, 155: 3102-PubMedGoogle Scholar
- Marzochi MC, Marzoci KBF, Carvalho RW: Visceral Leishmaniasis in Rio de Janeiro. Parasitology Today. 1994, 10: 37-10.1016/0169-4758(94)90358-1.View ArticlePubMedGoogle Scholar
- Kamau SW, Nunez R, Grimm F: Flow cytometry analysis of the effect of allopurinol and the dinitroaniline compound (Chloralin) on the viability and proliferation of Leishmania infantum promastigotes. BMC Pharmacol. 2001, 1 (1): 1-10.1186/1471-2210-1-1.View ArticlePubMedPubMed CentralGoogle Scholar
- Cinader B, Dubiski S, Wardlaw AC: Distribution, inheritance, and properties of an antigen, MUB1, and its relation to hemolytic complement. J Exp Med. 1964, 120: 897-10.1084/jem.120.5.897.View ArticlePubMedPubMed CentralGoogle Scholar
- Chagas E, Cunha AM, Ferreira LC, Deane G, Deane G, Guimaraes FN, Paugarten MJ, Von , SÁ B: Leishamniose visceral americana. Relatório dos trabalhos da Comissão encarregada dos estudos da leishmaniose visceral Americana em 1937. Mem Inst Oswaldo Cruz. 1938, 33: 89-View ArticleGoogle Scholar
- Deane LM, Deane MP: Visceral Leishmaniasis in Brazil. Geograhic distribution and transmission. Rev Inst Med Trop. 1962, 4: 198-Google Scholar
- Cunha S, Freire M, Eulalio C, Critosvao J, Netto E, Johnson WD, Reed SG, Badaro R: Visceral leishmaniasis in a new ecological niche near a major metropolitan area of Brazil. Trans R Soc Trop Med Hyg. 1995, 89 (2): 155-10.1016/0035-9203(95)90474-3.View ArticlePubMedGoogle Scholar
- Ashford DA, David JR, Freire M, David R, Sherlock I, Eulalio MC, Sampaio DP, Badaro R: Studies on control of visceral leishmaniasis: impact of dog control on canine and human visceral leishmaniasis in Jacobina, Bahia, Brazil. Am J Trop Med Hyg. 1998, 59: 53-PubMedGoogle Scholar
- Genaro O, Mayrink W, Michalick MSM, Dias M, Costa CA, Melo MN: Naturally occoring visceral Leishmaniasis in dogs: clinical aspects. Mem Inst Oswaldo Cruz. 1988, 83: 43-Google Scholar
- Michalick MSM: Spreading of visceral Leishmaniasis in urban area of Belo Horizonte, MG, Brazil. Mem Inst Oswaldo Cruz. 1993, 88 (supl I): 53-Google Scholar
- Bogliolo L: Nova contribuição ao conhecimento da anatomia patológica da leishmaniose visceral. A propósito de um caso brasileiro e com especial referência a fibrose hepática leishmaniótica. O Hospital. 1956, 3: 101-Google Scholar
- Deane LM, Deane MP: Leishmaniose visceral urbana (no cão e no homem) em Sobral, Ceará. O Hospital. 1955, 47: 75-Google Scholar
- Tafuri WL, Michalick MS, Dias M, Genaro O, Leite VH, Barbosa AJ, Bambirra EA, Da Costa CA, Melo MN, Mayrink W: Optical and electron microscopic study of the kidney of dogs naturally and experimentally infected with Leishmania (Leishmania) chagasi. Rev Inst Med Trop São Paulo. 1989, 3 (31): 139-View ArticleGoogle Scholar
- Pinelli E, Killick-Kendrick R, Wagenaar J, Bernadina W, del Real G, Ruitenberg J: Cellular and humoral immune response in dogs experimentally and naturally infected with Leishmania infantum. Infec Immun. 1994, 62: 229-Google Scholar
- Ciaramella P, Oliva G, Luna RD, Gradoni L, Ambrosio R, Cortese L, Scalone A, Persechino A: A retrospective clinical study of canine Leishmaniasis in 150 dogs naturally infected by Leishmania infantum. Vet Record. 1997, 22: 539-View ArticleGoogle Scholar
- Ferrer L: Clinical aspects of canine Leishmaniasis. Proceeding of the international canine leishmaniasis Forum Barcelona. 1999, 6-Google Scholar
- Tafuri , WgL , De Oliveira MR, Melo MN, Tafuri WL: Canine visceral Leishmaniasis: a remarkable histopathological picture of one case report from Brazil. Vet Parasitol. 2001, 3 (96): 203-10.1016/S0304-4017(00)00436-2.View ArticleGoogle Scholar
- Franca-Silva JC, da Costa RT, Siqueira AM, Machado-Coelho GL, da Costa CA, Mayrink W, Vieira EP, Costa JS, Genaro O, Nascimento E: Epidemiology of canine visceral leishmaniosis in the endemic area of Montes Claros Municipality, Minas Gerais State, Brazil. Vet Parasitol. 2003, 111 (2–3): 161-10.1016/S0304-4017(02)00351-5.View ArticlePubMedGoogle Scholar
- Mosser DM, Edelson PJ: Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages. J Immunol. 1984, 132: 1501-PubMedGoogle Scholar
- Tafuri WgL, Tafuri WL, Barbosa AJA: Histopathology and immunocytochemical study of type 3 and Type 4 complement receptors in the liver and spleen of dogs naturally and experimentally infected with Leishmania (Leishmania) chagasi. Rev Inst Med Trop São Paulo. 1996, 38 (2): 81-89.View ArticlePubMedGoogle Scholar
- Lehmann AK, Sornes S, Halstensen A: Phagocytosis: measurement by flow cytometry. J Immunol Methods. 2000, 243 (1–2): 229-42. 10.1016/S0022-1759(00)00237-4.View ArticlePubMedGoogle Scholar
- Bertho AL, Cysne L, Coutinho SG: Flow cytometry in the study of the interaction between murine macrophages and the protozoan parasite Leishmania amazonensis. J Parasitol. 1992, 78 (4): 666-View ArticlePubMedGoogle Scholar
- Adkins B, Williamson T, Guevara P, Bu Y: Murine neonatal lymphocytes show rapid early cell cycle entry and cell division. J Immunol. 2003, 170 (9): 4548-View ArticlePubMedGoogle Scholar
- Li X, Dancausse H, Grijalva I, Oliveira M, Levi AD: Labeling Schwann cells with CFSE-an in vitro and in vivo study. J Neurosci Methods. 2003, 125 (1–2): 83-10.1016/S0165-0270(03)00044-X.View ArticlePubMedGoogle Scholar
- Madakamutil LT, Maricic I, Sercarz E, Kumar V: Regulatory T cells control autoimmunity in vivo by inducing apoptotic depletion of activated pathogenic lymphocytes. J Immunol. 2003, 170 (6): 2985-View ArticlePubMedGoogle Scholar
- Watson AR, Mittler JN, Lee WT: Staphylococcal enterotoxin B induces anergy to conventional peptide in memory T cells. Cell Immunol. 2003, 222 (2): 144-10.1016/S0008-8749(03)00117-5.View ArticlePubMedGoogle Scholar
- Souza PE, Rocha MO, Rocha-Vieira E, Menezes CA, Chaves AC, Gollob KJ, Dutra WO: Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity. Infect Immun. 2004, 72 (9): 5283-10.1128/IAI.72.9.5283-5291.2004.View ArticlePubMedPubMed CentralGoogle Scholar
- Haugland RP: Handbook of fluorescent probes and research products. 2002, Eugene: Molecular Probes Inc, 9Google Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/5/39/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.